Gilead Sciences, Inc.
(NASDAQ:GILD)|
41.53 -1.67 (-3.87%) Nov 20 - Close |
|
|
|
After-Hours 42.50 +0.97 (2.34%) Thu, 20 Nov 2008 6:50 PM
- Compare GILD with:
- View: Line | Candlestick
Company Profile
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
United States - Map
Phone: (650) 574-3000
Fax: (650) 578-9264
Website: www.gilead.com
State of incorporation: Delaware
CEO: Dr. John C. Martin, M.D., Ph.D.
Employees: 2,979
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Disc/dev pharmaceuticals based on nucleotides
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
Recent news for GILD
-
Five Healthcare Stocks for a Diversified Portfolio
Seeking Alpha - 16 hours ago
-
Final Glance: Biotechnology companies
AP - Yesterday at 5:47 ET
-
TheStreet.com - Yesterday at 2:42 ET
-
Midday Glance: Biotechnology companies
AP - Yesterday at 1:19 ET
-
Early Glance: Biotechnology companies
AP - Yesterday at 10:56 ET
-
Financial Outlook for Biotechnology Companies Discussed in Wall Street Transcript Report
Wall Street Transcript - Yesterday at 9:16 ET
-
5 Healthcare Stocks for Value Investors
Seeking Alpha - Yesterday at 4:55 ET
-
Final Glance: Biotechnology companies
AP - Nov 18 at 5:38 ET
-
Midday Glance: Biotechnology companies
AP - Nov 18 at 1:13 ET
-
Early Glance: Biotechnology companies
AP - Nov 18 at 10:42 ET
